| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant somatic hypermutations in thyroid lymphomas
|
Takakuwa, Tetsuya
|
|
2009
|
33 |
5 |
p. 649-654
6 p.
|
artikel
|
| 2 |
Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease
|
Breccia, Massimo
|
|
2009
|
33 |
5 |
p. 645-648
4 p.
|
artikel
|
| 3 |
A tumour stage-dependent evolution of drug resistant T cell lymphoma: Role of soluble mediators of tumour and host origin
|
Singh, Vivek
|
|
2009
|
33 |
5 |
p. 700-709
10 p.
|
artikel
|
| 4 |
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KITD816V
|
Ustun, Celalettin
|
|
2009
|
33 |
5 |
p. 735-741
7 p.
|
artikel
|
| 5 |
Compound 48, a novel dual PPAR α/γ ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib
|
Bertz, Janina
|
|
2009
|
33 |
5 |
p. 686-692
7 p.
|
artikel
|
| 6 |
Converting cell lines representing hematological malignancies from glucocorticoid-resistant to glucocorticoid-sensitive: Signaling pathway interactions
|
Garza, Anna S.
|
|
2009
|
33 |
5 |
p. 717-727
11 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2009
|
33 |
5 |
p. CO2-
1 p.
|
artikel
|
| 8 |
Endogenous inhibitors of angiogenesis
|
Ribatti, Domenico
|
|
2009
|
33 |
5 |
p. 638-644
7 p.
|
artikel
|
| 9 |
Has the time come for induction and maintenance imatinib therapy in chronic myeloid leukemia?
|
Faber, Edgar
|
|
2009
|
33 |
5 |
p. 605-606
2 p.
|
artikel
|
| 10 |
High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin’s lymphoma
|
Green, Michael
|
|
2009
|
33 |
5 |
p. 731-734
4 p.
|
artikel
|
| 11 |
How to restore normal innate antitumor immunity in acute leukemia?
|
Costello, Régis T.
|
|
2009
|
33 |
5 |
p. 613-
1 p.
|
artikel
|
| 12 |
Imatinib resistance in multidrug-resistant K562 human leukemic cells
|
Assef, Yanina
|
|
2009
|
33 |
5 |
p. 710-716
7 p.
|
artikel
|
| 13 |
Immunophenotyping and immunoglobulin heavy chain gene rearrangement analysis in cerebrospinal fluid of pediatric patients with acute lymphoblastic leukemia
|
Sayed, Douaa
|
|
2009
|
33 |
5 |
p. 655-661
7 p.
|
artikel
|
| 14 |
In vitro biology of human myeloid leukemia
|
Mayani, Hector
|
|
2009
|
33 |
5 |
p. 624-637
14 p.
|
artikel
|
| 15 |
Is WT1 helping the molecular monitoring of minimal residual disease to get easier in acute myeloid leukaemia?
|
Cilloni, Daniela
|
|
2009
|
33 |
5 |
p. 603-604
2 p.
|
artikel
|
| 16 |
John Auer and Auer rods; controversies revisited
|
Yoshida, Yataro
|
|
2009
|
33 |
5 |
p. 614-616
3 p.
|
artikel
|
| 17 |
Methyltransferases in myelodysplastic syndromes: Guilty or not guilty?
|
Quesnel, Bruno
|
|
2009
|
33 |
5 |
p. 601-602
2 p.
|
artikel
|
| 18 |
Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines
|
Guo, Dongmei
|
|
2009
|
33 |
5 |
p. 678-685
8 p.
|
artikel
|
| 19 |
Oligonucleotide array CGH studies in myeloproliferative neoplasms: Comparison with JAK2V617F mutational status and conventional chromosome analysis
|
Tefferi, Ayalew
|
|
2009
|
33 |
5 |
p. 662-664
3 p.
|
artikel
|
| 20 |
Preclinical and clinical experience with dasatinib in philadelphia chromosome-negative leukemias and myeloid disorders
|
Verstovsek, Srdan
|
|
2009
|
33 |
5 |
p. 617-623
7 p.
|
artikel
|
| 21 |
PTEN deficiency is a common defect in juvenile myelomonocytic leukemia
|
Liu, Yunying Lucy
|
|
2009
|
33 |
5 |
p. 671-677
7 p.
|
artikel
|
| 22 |
Renal intravascular large B-cell lymphoma with early diagnosis by renal biopsy: A case report and review of the literature
|
Niitsu, Nozomi
|
|
2009
|
33 |
5 |
p. 728-730
3 p.
|
artikel
|
| 23 |
The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma
|
Yang, Deok-Hwan
|
|
2009
|
33 |
5 |
p. 665-670
6 p.
|
artikel
|
| 24 |
The power of comparative studies
|
Walter, Roland B.
|
|
2009
|
33 |
5 |
p. 610-612
3 p.
|
artikel
|
| 25 |
The p38 pathway inhibitor SB202190 activates MEK/MAPK to stimulate the growth of leukemia cells
|
Hirosawa, Megumi
|
|
2009
|
33 |
5 |
p. 693-699
7 p.
|
artikel
|
| 26 |
Thyroid lymphoma: Beyond antigen stimulation
|
Rossi, Davide
|
|
2009
|
33 |
5 |
p. 607-609
3 p.
|
artikel
|
Tijdschrift beschrijving